The ongoing COVID-19 pandemic has been a scientific, medical and social challenge. Since clinical course of this disease is largely unpredictable and can develop rapidly causing severe complications, it is important to identify laboratory biomarkers, which may help to classify patient's severity during initial stage. Previous studies have suggested C-reactive protein (inflammatory) and D-dimer (biochemical) as an effective biomarker. The differential severity in patients across the world and our limited understanding in the progression of the disease calls for a multi-country analysis for biomarkers. Therefore, we have analyzed these biomarkers among 228 Bangladeshi COVID-19 patients. We observed significant association of COVID-19 severity with these two biomarkers. Thus, we suggest to use these biomarkers for Bangladeshi COVID-19 patients for better disease monitoring. Such validated preventive measures may decrease the case fatality ratio substantially.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780378PMC
http://dx.doi.org/10.3389/fgene.2022.966595DOI Listing

Publication Analysis

Top Keywords

bangladeshi covid-19
12
covid-19 patients
12
c-reactive protein
8
severe complications
8
covid-19
5
biomarkers
5
studying c-reactive
4
protein d-dimer
4
d-dimer levels
4
levels blood
4

Similar Publications

Background: Sotrovimab is a neutralising monoclonal antibody (nMAB) currently available to treat extremely clinically vulnerable COVID-19 patients in England. Trials have shown it to have mild to moderate side effects, however, evidence regarding its safety in real-world settings remains insufficient.

Methods: Descriptive and multivariable logistic regression analyses were conducted to evaluate uptake, and a self-controlled case series analysis performed to measure the risk of hospital admission (hospitalisation) associated with 49 pre-specified suspected adverse outcomes in the period 2-28 days post-Sotrovimab treatment among eligible patients treated between December 11, 2021 and May 24, 2022.

View Article and Find Full Text PDF

Background: Acute lower respiratory tract infections (ALRIs) remain the leading infectious cause of death among children < 5 years, with viruses contributing to a large proportion of cases. Little is known about the epidemiology and etiology of viral ALRI in rural Bangladesh.

Methods: We enrolled 3- to 23-month-old children with ALRIs attending a subdistrict hospital outpatient clinic in Sylhet district in Bangladesh.

View Article and Find Full Text PDF

Objective: In COVID-19, cytokine storms (CS) result in higher mortality and morbidity. Our study evaluated the rate of cytokine storms among COVID-positive Bangladeshi adults.

Methods: From October 2020 to March 2022, this cohort study enrolled both COVID-positive and COVID-negative healthy adults.

View Article and Find Full Text PDF

A nationwide lockdown and deaths due to COVID-19 in the Indian subcontinent.

Epidemics

October 2023

Chair of Biostatistics, Department of Mathematics, Ecole Polytechnique Federale de Lausanne, Switzerland.

During the COVID-19 pandemic, the effects of nationwide lockdowns on health outcomes have been widely studied in Western, developed countries. However, the effects of lockdowns in emerging and developing countries are largely unknown. We used data from India and Bangladesh to study the effect of nationwide restrictions on public movement in Bangladesh in April 2021 on health outcomes, specifically COVID-19 incidence and mortality.

View Article and Find Full Text PDF

Migratory birds are a natural reservoir for major respiratory viruses such as the avian influenza virus (AIV) and the avian coronavirus (AvCoV). Transmission of these viruses from migratory birds to domestic birds increases the prevalence of those diseases that cause severe economic and public health concerns in Bangladesh. The study focused on active surveillance of major respiratory viral pathogens in migratory birds, molecular identification of the viruses, and their phylogenetic origin.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!